Contact Us
07.27.2021 17:21
Go to next video when video is over

Biontech aims to develop MRNA-based malaria vaccine

"Our goal is to develop a vaccine which makes the malaria parasite visible and attackable by the immune system from the very beginning when it is most vulnerable," Biontech CEO Uğur Şahin said in his comments.